Helius Medical Technologies (HSDT)
(Delayed Data from NSDQ)
$1.79 USD
-0.01 (-0.56%)
Updated May 8, 2024 04:00 PM ET
After-Market: $1.81 +0.02 (1.12%) 7:46 PM ET
2-Buy of 5 2
D Value D Growth B Momentum D VGM
Fundamental Charts
About Cash from Investing (Quarterly)
The company's quarterly Cash from Investing value is the sum of the company's current quarter cash position resulting from any gains or losses from investments in the financial markets, operating activities, and changes resulting from amounts spent on investments in capital assets such as plant and equipment. When evaluating the Cash from Investing value, it is important to consider each of the various activities which contribute to the overall change in cash position. A company can have a negative cash flow from investing and have a positive cash from Cash from operations or financing.
HSDT 1.79 -0.01(-0.56%)
Will HSDT be a Portfolio Killer in May?
Zacks Investment Research is releasing its prediction for HSDT based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for HSDT
Nevro (NVRO) Reports Q1 Loss, Tops Revenue Estimates
AxoGen (AXGN) Reports Q1 Loss, Lags Revenue Estimates
HSDT: What are Zacks experts saying now?
Zacks Private Portfolio Services
Wall Street Analysts Predict a 1249.93% Upside in Helius Medical Technologies, Inc. (HSDT): Here's What You Should Know
How Much Upside is Left in Helius Medical Technologies, Inc. (HSDT)? Wall Street Analysts Think 1183.3%
Helius Medical Technologies, Inc. (HSDT) Reports Q2 Loss, Tops Revenue Estimates
Other News for HSDT
NKTR, BRFS and SEED are among premarket gainers
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
PEGY, MTC and IMTE among mid-day movers
12 Health Care Stocks Moving In Tuesday's Intraday Session
Why Zeta Global Shares Are Trading Higher By 15%; Here Are 20 Stocks Moving Premarket